Status:
UNKNOWN
Transauricular Vagus Nerve Stimulation in the Treatment of Chemotherapy-induced Peripheral Neuropathy
Lead Sponsor:
Peking University People's Hospital
Conditions:
CIPN
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chemotherapy induced peripheral neuropathy is common in tumor patients receiving chemotherapy. Nowaday, CIPN is mainly treated with drugs, but the therapeutic effect is not satisfactory. Previous stud...
Eligibility Criteria
Inclusion
- Patient is currently receiving chemotherapy drugs with neurotoxicity
- New or worsening numbness and / or pain in the hands and / or feet, and no other cause explains the above symptoms
Exclusion
- Patients with sinus bradycardia, long QT syndrome, sick sinus syndrome or other arrhythmias, mental diseases, cardiac pacemakers or other electrical stimulation devices after implantation.
- Patients taking analgesics due to pain in other parts of the body.
Key Trial Info
Start Date :
June 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05434403
Start Date
June 2 2022
End Date
November 1 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
People's Hospital of Peking University
Beijing, Beijing Municipality, China, 100044